• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co advised Lee Biosolution on its sale to Medix Biochemica

Bryan, Garnier & Co acts as Sole Financial Advisor to Ingenico Group on the carve-out of its French healthcare business to Andera Partners

Ingenico_website_tombstone

Majority sale of NOX Consulting AB

Nox_tombstone_nov19

Bryan, Garnier & Co accompanies DBV on its USD 143 million NASDAQ Follow-on

DBV_website_tombstone_2019

Minority sale of Partyking

Partyking_tombstone_oct19

Bryan, Garnier & Co acts as Joint Bookrunner to BioNTech on its USD 150 million Nasdaq Initial Public Offering

Biontech_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Keensight Capital on its majority investment in Geodesial

Geodesial_website_tombstone

Wise divestment by Akva Group

Wise_tombstone_sept19

Bryan, Garnier & Co acts as Joint Bookrunning Manager on Celyad’s USD 20 million global equity offering

Celyad_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Inotrem on its EUR 44 million Series B Fundraising

Inotrem_website_tombstone

Bryan, Garnier & Co acts as Sole Advisor to Argos Wityu and the real estate management software provider Salvia Developpement on its sale to Total Specific Solutions (TSS)

Salvia transaction tombstone image

Talen-X acquired by Orolia SAS

TalenX_tombstone_sep19
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 50

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }